Surmodics, Inc. (SRDX)

Surmodics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	41.42	19	31.15	30.79	30.36
Short-Term Investments	3.93	0	7.72	30.31	24.93
Cash & Cash Equivalents	45.35	19	38.87	61.1	55.29
Cash Growth	138.72%	-51.12%	-36.38%	10.50%	-14.96%
Receivables	10.85	10.45	9.17	7.68	8.99
Inventory	14.84	11.82	6.76	5.97	4.5
Other Current Assets	15.65	16.32	15.46	11.87	12.63
Total Current Assets	86.69	57.59	70.26	86.61	81.42
Property, Plant & Equipment	26.03	27.15	30.09	30.1	29.75
Long-Term Investments	0	0	2	0	0
Goodwill and Intangibles	69.15	68.86	82.66	40.47	40.4
Other Long-Term Assets	3.86	4.77	9.59	11.58	8.3
Total Long-Term Assets	99.04	100.77	124.34	82.16	78.45
Total Assets	185.73	158.36	194.59	168.76	159.87
Accounts Payable	2.99	3.14	1.78	1.52	2.09
Deferred Revenue	6.78	9.25	14.95	16	17.18
Current Debt	0	10	10	0	0
Other Current Liabilities	14.18	9.7	3.08	1.38	0.94
Total Current Liabilities	23.95	32.08	29.82	18.89	20.21
Long-Term Debt	29.41	0	0	0	0
Other Long-Term Liabilities	12.46	17.89	24.69	18.82	17.14
Total Long-Term Liabilities	41.87	17.89	24.69	18.82	17.14
Total Liabilities	65.82	49.97	54.51	37.71	37.35
Total Debt	29.41	10	10	0	0
Debt Growth	194.05%	-	-	-	-
Retained Earnings	87.26	88.79	116.07	111.83	110.71
Comprehensive Income	-4.76	-9.87	1.73	3.17	0.4
Shareholders' Equity	119.91	108.39	140.09	131.06	122.52
Net Cash / Debt	15.95	9	28.87	61.1	55.29
Net Cash / Debt Growth	77.23%	-68.83%	-52.75%	10.50%	-14.96%
Net Cash Per Share	1.14	0.65	2.06	4.42	4.01
Working Capital	62.74	25.51	40.44	67.72	61.21
Book Value Per Share	8.55	7.79	10.18	9.67	9.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).